X @Bloomberg
Norway’s sovereign wealth fund is among investors renouncing a revamp of the board of directors at obesity-drug maker Novo https://t.co/SRLnVcRPn4 ...
Norway’s sovereign wealth fund is among investors renouncing a revamp of the board of directors at obesity-drug maker Novo https://t.co/SRLnVcRPn4 ...